FDA.reportPublic FDA data

CARISOPRODOL

Substance profile for UNII 21925K482H, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for CARISOPRODOL
Structure render from PubChem CID 2576

Substance Identity#

UNII
21925K482H
Preferred term
CARISOPRODOL
Registry number
78-44-4
EC number
201-118-7
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C12H24N2O4
Chemical structure for CARISOPRODOL
Structure render from PubChem CID 2576

Chemical And Database Identifiers#

SMILES
CCCC(C)(COC(N)=O)COC(=O)NC(C)C
RxCUI
2101
PubChem
2576
NCIt
C28904
INN ID
902

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem Compound2576pubchem.ncbi.nlm.nih.gov/compound/2576
RxNorm2101mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=2101
NCI ThesaurusC28904ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C28904
FDA Substance Registration System21925K482Hprecision.fda.gov/uniisearch/srs/unii/21925K482H
European Community number201-118-7commonchemistry.cas.org/results?q=201-118-7

DailyMed Socrata Ingredients#

Type, DailyMed label, SPL version table
TypeDailyMed labelSPL version
ACTIVE MOIETYCARISOPRODOL2
ACTIVE INGREDIENTCARISOPRODOL2
ACTIVE MOIETYThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
ACTIVE INGREDIENTThese highlights do not include all the information needed to use CARISOPRODOL safely and effectively. See full prescribing information for CARISOPRODOL CARISOPRODOL Tablets for Oral Use Initial U.S. Approval: 19591
ACTIVE MOIETYThese highlights do not include all the information needed to use CARISOPRODOL safely and effectively. See full prescribing information for CARISOPRODOL CARISOPRODOL Tablets for Oral Use Initial U.S. Approval: 19591
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. CARISOPRODOL Tablets USP for Oral use CIV Initial U.S. Approval: 19591
ACTIVE MOIETYThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. CARISOPRODOL Tablets USP for Oral use CIV Initial U.S. Approval: 19591
ACTIVE INGREDIENTefc83b8d-2550-4f2b-9775-17958eb3dd6b5
ACTIVE MOIETYefc83b8d-2550-4f2b-9775-17958eb3dd6b5
ACTIVE INGREDIENTThese highlights do not include all the information needed to use CARISOPRODOL safely and effectively. See full prescribing information for CARISOPRODOL CARISOPRODOL Tablets for Oral Use Initial U.S. Approval: 19592
ACTIVE MOIETYThese highlights do not include all the information needed to use CARISOPRODOL safely and effectively. See full prescribing information for CARISOPRODOL CARISOPRODOL Tablets for Oral Use Initial U.S. Approval: 19592
ACTIVE MOIETY3197e424-ac97-4667-b64d-503581f5edc11
ACTIVE INGREDIENT3197e424-ac97-4667-b64d-503581f5edc11
ACTIVE MOIETYThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. CARISOPRODOL Tablets USP for Oral use CIV Initial U.S. Approval: 19592
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. CARISOPRODOL Tablets USP for Oral use CIV Initial U.S. Approval: 19592
ACTIVE MOIETYThese highlights do not include all the information needed to use CARISOPRODOL tablets USP safely and effectively. See full prescribing information for carisoprodol. CARISOPRODOL tablets, USP for oral use, C-IV Initial U.S. Approval: 19598
ACTIVE INGREDIENTThese highlights do not include all the information needed to use CARISOPRODOL tablets USP safely and effectively. See full prescribing information for carisoprodol. CARISOPRODOL tablets, USP for oral use, C-IV Initial U.S. Approval: 19598
ACTIVE MOIETYThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use Initial U.S. Approval: 19593
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use Initial U.S. Approval: 19593
ACTIVE MOIETYThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use CIV Initial U.S. Approval: 19591
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use CIV Initial U.S. Approval: 19591
ACTIVE INGREDIENTCarisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19594
ACTIVE MOIETYCarisoprodol Tablets, USP C-IV Rx Only Rev. 01/12 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19594
ACTIVE MOIETYCarisoprodol Tablets, USP C-IV Rx Only These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
ACTIVE INGREDIENTCarisoprodol Tablets, USP C-IV Rx Only These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
ACTIVE INGREDIENTCARISOPRODOL AND ASPIRIN TABLETS, USP 200 mg/325 mg1
ACTIVE MOIETYCARISOPRODOL AND ASPIRIN TABLETS, USP 200 mg/325 mg1
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use CIV Initial U.S. Approval: 19593
ACTIVE MOIETYThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use CIV Initial U.S. Approval: 19593
ACTIVE MOIETYThese highlights do not include all the information needed to use C arisoprodol Tablets USP safely and effectively. See full prescribing information for carisoprodol . C arisoprodol Tablets for Oral use Initial U.S. Approval: 19591
ACTIVE INGREDIENTThese highlights do not include all the information needed to use C arisoprodol Tablets USP safely and effectively. See full prescribing information for carisoprodol . C arisoprodol Tablets for Oral use Initial U.S. Approval: 19591
ACTIVE MOIETYThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19593
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19593
ACTIVE INGREDIENTCarisoprodol Tablets, USP Rx only Rev. 09/09 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Initial U.S. Approval Carisoprodol Tablets for Oral use18
ACTIVE MOIETYCarisoprodol Tablets, USP Rx only Rev. 09/09 These highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Initial U.S. Approval Carisoprodol Tablets for Oral use18
ACTIVE MOIETYThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use Initial U.S. Approval: 19591
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use Initial U.S. Approval: 19591
ACTIVE MOIETYThese highlights do not include all the information needed to use SOMA safely and effectively. See full prescribing information for SOMA. SOMA (carisoprodol) Tablets for Oral use Initial U.S. Approval: 19591
ACTIVE INGREDIENTThese highlights do not include all the information needed to use SOMA safely and effectively. See full prescribing information for SOMA. SOMA (carisoprodol) Tablets for Oral use Initial U.S. Approval: 19591
ACTIVE MOIETYThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use Initial U.S. Approval: 19595
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Carisoprodol Tablets, USP safely and effectively. See full prescribing information for Carisoprodol Tablets, USP. Carisoprodol Tablets for Oral use Initial U.S. Approval: 19595
ACTIVE MOIETYCARISOPRODOL AND ASPIRIN 200MG/325MG USP Rx Only1
ACTIVE INGREDIENTCARISOPRODOL AND ASPIRIN 200MG/325MG USP Rx Only1
ACTIVE MOIETYThese highlights do not include all the information needed to use SOMA safely and effectively. See full prescribing information for SOMA. SOMA (carisoprodol) Tablets for Oral use Initial U.S. Approval: 19591
ACTIVE INGREDIENTThese highlights do not include all the information needed to use SOMA safely and effectively. See full prescribing information for SOMA. SOMA (carisoprodol) Tablets for Oral use Initial U.S. Approval: 19591
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
ACTIVE MOIETYThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
ACTIVE MOIETYThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19591
ACTIVE MOIETYThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19592
ACTIVE INGREDIENTThese highlights do not include all the information needed to use Carisoprodol Tablets safely and effectively. See full prescribing information for Carisoprodol Tablets. Carisioprodol Tablets, USP for Oral Use. Initial U.S. Approval: 19592
ACTIVE MOIETYCARISOPRODOL TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3970
ACTIVE INGREDIENTCARISOPRODOL TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3970
ACTIVE INGREDIENTSOMA (CARISOPRODOL ) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3830
ACTIVE MOIETYSOMA (CARISOPRODOL ) TABLET [LAKE ERIE MEDICAL & SURGICAL SUPPLY DBA QUALITY CARE PRODUCTS LLC]3830
ACTIVE MOIETYCARISOPRODOL TABLET [BRYANT RANCH PREPACK]1000
ACTIVE MOIETYCARISOPRODOL TABLET [BRYANT RANCH PREPACK]1000
ACTIVE INGREDIENTCARISOPRODOL TABLET [BRYANT RANCH PREPACK]1000
ACTIVE INGREDIENTCARISOPRODOL TABLET [BRYANT RANCH PREPACK]1000
ACTIVE MOIETYCARISOPRODOL TABLET [QUALITEST PHARMACEUTICALS]18
ACTIVE INGREDIENTCARISOPRODOL TABLET [QUALITEST PHARMACEUTICALS]18
ACTIVE MOIETYCARISOPRODOL TABLET [WATSON LABORATORIES, INC.]16
ACTIVE INGREDIENTCARISOPRODOL TABLET [WATSON LABORATORIES, INC.]16
ACTIVE INGREDIENTCARISOPRODOL TABLET [WEST-WARD PHARMACEUTICAL CORP]13
ACTIVE MOIETYCARISOPRODOL TABLET [WEST-WARD PHARMACEUTICAL CORP]13
ACTIVE MOIETYCARISOPRODOL TABLET [AUROBINDO PHARMA LIMITED]10
ACTIVE INGREDIENTCARISOPRODOL TABLET [AUROBINDO PHARMA LIMITED]10
ACTIVE INGREDIENTCARISOPRODOL TABLET [WEST-WARD PHARMACEUTICAL CORP]10
ACTIVE MOIETYCARISOPRODOL TABLET [WEST-WARD PHARMACEUTICAL CORP]10
ACTIVE INGREDIENTSOMA (CARISOPRODOL ) TABLET [MEDA PHARMACEUTICALS INC.]9
ACTIVE MOIETYSOMA (CARISOPRODOL ) TABLET [MEDA PHARMACEUTICALS INC.]9
ACTIVE MOIETYCARISOPRODOL TABLET [MIRROR PHARMACEUTICALS LLC]7
ACTIVE INGREDIENTCARISOPRODOL TABLET [MIRROR PHARMACEUTICALS LLC]7
ACTIVE INGREDIENTCARISOPRODOL TABLET [PD-RX PHARMACEUTICALS, INC.]7
ACTIVE MOIETYCARISOPRODOL TABLET [PD-RX PHARMACEUTICALS, INC.]7
ACTIVE INGREDIENTCARISOPRODOL TABLET [PD-RX PHARMACEUTICALS, INC.]7
ACTIVE MOIETYCARISOPRODOL TABLET [PD-RX PHARMACEUTICALS, INC.]7
ACTIVE INGREDIENTCARISOPRODOL TABLET [UNIT DOSE SERVICES]7
ACTIVE MOIETYCARISOPRODOL TABLET [UNIT DOSE SERVICES]7
ACTIVE MOIETYCARISOPRODOL TABLET [PREFERRED PHARMACEUTICALS, INC.]6
ACTIVE INGREDIENTCARISOPRODOL TABLET [PREFERRED PHARMACEUTICALS, INC.]6
ACTIVE INGREDIENTCARISOPRODOL AND ASPIRIN TABLET [EON LABS, INC.]5
ACTIVE MOIETYCARISOPRODOL AND ASPIRIN TABLET [EON LABS, INC.]5
ACTIVE INGREDIENTCARISOPRODOL TABLET [AMERICAN HEALTH PACKAGING]5
ACTIVE MOIETYCARISOPRODOL TABLET [AMERICAN HEALTH PACKAGING]5
ACTIVE INGREDIENTCARISOPRODOL TABLET [CARDINAL HEALTH]5
ACTIVE MOIETYCARISOPRODOL TABLET [CARDINAL HEALTH]5
ACTIVE MOIETYCARISOPRODOL TABLET [PREFERRED PHARMACEUTICALS, INC.]5
ACTIVE INGREDIENTCARISOPRODOL TABLET [PREFERRED PHARMACEUTICALS, INC.]5
ACTIVE MOIETYCARISOPRODOL TABLET [SUN PHARMACEUTICAL INDUSTRIES LIMITED ]5
ACTIVE INGREDIENTCARISOPRODOL TABLET [SUN PHARMACEUTICAL INDUSTRIES LIMITED ]5
ACTIVE MOIETYCARISOPRODOL AND ASPIRIN TABLET [HERITAGE PHARMACEUTICALS INC.]4
ACTIVE INGREDIENTCARISOPRODOL AND ASPIRIN TABLET [HERITAGE PHARMACEUTICALS INC.]4
ACTIVE INGREDIENTCARISOPRODOL AND ASPIRIN TABLET [MIRROR PHARMACEUTICALS LLC]4
ACTIVE MOIETYCARISOPRODOL AND ASPIRIN TABLET [MIRROR PHARMACEUTICALS LLC]4
ACTIVE INGREDIENTCARISOPRODOL TABLET [APOTHECA, INC.]4
ACTIVE MOIETYCARISOPRODOL TABLET [APOTHECA, INC.]4
ACTIVE INGREDIENTCARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE TABLET [EON LABS, INC.]4
ACTIVE MOIETYCARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE TABLET [EON LABS, INC.]4
ACTIVE MOIETYCARISOPRODOL (CARISOPRODOL ) TABLET [WALLACE PHARMACEUTICALS INC.]3
ACTIVE INGREDIENTCARISOPRODOL (CARISOPRODOL ) TABLET [WALLACE PHARMACEUTICALS INC.]3
ACTIVE INGREDIENTCARISOPRODOL IMMEDIATE RELEASE (CARISOPRODOL) TABLET [VENSUN PHARMACEUTICALS, INC]3
ACTIVE MOIETYCARISOPRODOL IMMEDIATE RELEASE (CARISOPRODOL) TABLET [VENSUN PHARMACEUTICALS, INC]3
ACTIVE INGREDIENTCARISOPRODOL TABLET [BRYANT RANCH PREPACK]3
ACTIVE MOIETYCARISOPRODOL TABLET [BRYANT RANCH PREPACK]3
ACTIVE INGREDIENTCARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE TABLET [RISING PHARMACEUTICALS, INC.]3
ACTIVE MOIETYCARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE TABLET [RISING PHARMACEUTICALS, INC.]3
ACTIVE INGREDIENTCARISOPRODOL TABLET [BIONPHARMA INC.]2
ACTIVE MOIETYCARISOPRODOL TABLET [BIONPHARMA INC.]2
ACTIVE INGREDIENTCARISOPRODOL TABLET [CARDINAL HEALTH]2
ACTIVE MOIETYCARISOPRODOL TABLET [CARDINAL HEALTH]2
ACTIVE INGREDIENTCARISOPRODOL TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]2
ACTIVE MOIETYCARISOPRODOL TABLET [GOLDEN STATE MEDICAL SUPPLY, INC.]2
ACTIVE INGREDIENTCARISOPRODOL TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2
ACTIVE MOIETYCARISOPRODOL TABLET [LAKE ERIE MEDICAL DBA QUALITY CARE PRODUCTS LLC]2
ACTIVE INGREDIENTCARISOPRODOL TABLET [MCKESSON PACKAGING SERVICES A BUSINESS UNIT OF MCKESSON CORPORATION]2
ACTIVE MOIETYCARISOPRODOL TABLET [MCKESSON PACKAGING SERVICES A BUSINESS UNIT OF MCKESSON CORPORATION]2
ACTIVE MOIETYCARISOPRODOL TABLET [MEDSOURCE PHARMACEUTICALS]2
ACTIVE INGREDIENTCARISOPRODOL TABLET [MEDSOURCE PHARMACEUTICALS]2